An Exploratory Study of Golidocitinib in Adult Patients With ITP

NCT07196163 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

138

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia (ITP)

Interventions

DRUG: Golidocitinib
DRUG: Placebo

Sponsor

Peking University People's Hospital